Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade–Resistant Advanced NSCLC
Titel:
Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade–Resistant Advanced NSCLC
Auteur:
Negrao, Marcelo V. Papadimitrakopoulou, Vassiliki A. Price, Andrew C. Tam, Alda L. Furqan, Muhammad Laroia, Sandeep T. Massarelli, Erminia Pacheco, Jose Heymach, John V. Tsao, Anne S. Walker, Gary V. Vora, Lalit Mauro, David Kelley, Heather Wooldridge, James E. Krieg, Arthur M. Niu, Jiaxin